Skip to ContentGo to accessibility page

Key Terms

adverse drug event
when an individual is harmed by a drug
adverse effect
an effect of a drug that is undesired
biologic
a drug isolated from natural resources and developed through biomolecular science, immunology, and genetic engineering and produced through biotechnological processes
biosimilar
a drug that is synthetically produced and has similar properties to a specific biologic; although it does go through testing, it does not go through the same rigorous testing that a biologic does
brand name
the unique identifier of a drug assigned by the drug company and marketed to consumers; also known as a trade name
chemical name
a method for identifying drugs built around the drug’s specific chemical structure or composition; often of most use to the chemist or pharmacist
complementary and alternative medicine (CAM)
alternative medicine refers to using a treatment instead of mainstream conventional medicine. Complementary therapy refers to using both alternative and conventional medicine together. Treatments may include massage, acupuncture, acupressure, mind–body interventions, herbs, vitamins, or dietary supplements.
counterfeit drug
a product that is illegally manufactured or mislabeled regarding the identity or source and appears to be a genuine product; may be harmful to the client
drug
a chemical that exerts an effect on the living body; a compound used in the prevention, treatment, diagnosis, or cure of a condition or disease
drug formulary
the list of prescription drugs that are covered by an insurance plan or carried by a medical institution
drug prototype
use of one drug within a class to represent all other drugs within the class—a “class representative”
enteral administration
the administration of medications into the gastrointestinal (GI) tract
generic name
the name of a drug, usually derived from the chemical name, that uniquely identifies the drug
intramuscular injection
the administration of medication into the muscle of a client (usually deltoid or ventrogluteal in an adult and the vastus lateralis in an infant under age 2)
intravenous
the administration of a medication directly into the bloodstream through a vein
over-the-counter (OTC) drug
a drug or medication available without prescription
parenteral administration
the administration of medication elsewhere besides the enteral (GI) route
percutaneous administration
the application of drugs to the skin or mucous membranes
pharmacogenetics
the study of the body’s hereditary response to drugs
pharmacokinetics
the movement of a drug through the body, or “what the body does to the drug”
pharmacologic classification
refers to how a group of drugs can be organized by how they work in the body—the mechanism of action
pharmacology
the study of medicines (or drugs) or the study of the biological effects of chemicals on the body
side effect
an effect of a drug that is undesired
subcutaneous injection
the administration of a medication into adipose tissue
synthetic drug
a chemical compound produced in a laboratory by a drug manufacturer or illegally by individuals for illicit purposes
teratogenic
harmful to a fetus by causing severe malformations or death
therapeutic classification
refers to how a group of drugs can be organized by the diagnosis or disease being treated
therapeutic effects
the effects that are expected and desired from a particular medication
Citation/Attribution
Reuse and redistribution of this content in digital or print format:
  • This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's prior written permission.
  • This book uses the Creative Commons Attribution-NonCommercial-ShareAlike License, which means that you can reuse and modify the material only for noncommercial purposes, must attribute OpenStax, and must distribute any derivative works under the same license.
  • Any commercial printing of this textbook, including using a local or custom printer, must be approved by OpenStax, and proper citation provided.
  • OpenStax-copyrighted images, activities, assessments, and similar components of this book are subject to the same licensing – CC-BY-NC-SA. They can be used for noncommercial purposes with attribution. Commercial use requires permission.
  • Permission requests: Anyone who intends to incorporate this content (including text, images, and other components) into large language models, use it in AI offerings, use it commercially (including in print), and/or has questions about another use case is welcome to complete our reuse request form.
Attribution information
  • If you are redistributing all or part of this book in a noncommercial print format, then you must include on every physical page the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

  • If you are redistributing all or part of this book in a noncommercial digital format, then for every page that includes OpenStax content, you must license the derivative work under the same CC-BY-NC-SA license as the original, and include on every digital page view the following attribution:

    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction

Citation information

The information below includes the information needed to generate citations in most major styles (APA, MLA, etc.); you must reformat and organize the information as needed to fit the requirements of the style. Use the information below to generate a citation. We recommend using a citation tool such as this one.

© Apr 23, 2026 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo, and Rice University name, and Rice University logo trademarks, or wordmarks are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.